Consequently, Glial Fibrillary Acidic Protein (GFAP) staining has been widely used to identify reactive glia in a variety of central nervous system diseases including TBI (Pekny and Pekna, 2014). The gene discussed is GFAP; the disease is central nervous system disorder.